New Treatment Effective In Up To 73% Of Multiple Myeloma Patients!
Cancer Institute Hospital of JFCR
Royal Marsden Cancer Centre
Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval
New Research: Cracking The Targeted Drug Resistance Puzzle And Eliminating Cancer Cells Before They Evolve!
Car-T Therapy Ide-Cel For Multiple Myeloma Prolongs Patient Survival By 2-Fold!
